Homburger | View firm profile
On July 28, 2025, a consortium led by EQT, consisting of Sunshine SwissCo GmbH, the Abu Dhabi Investment Authority (ADIA) and Auba Investment Pte. Ltd. (all acting as the Sellers), announced the launch of an accelerated bookbuilding process to professional investors in Switzerland and to qualified investors outside Switzerland, which led to the successful placement of 17 million shares in Galderma Group AG (Galderma) at a price of CHF 123 per share (the Placement), raising a total of ca. CHF 2,091 million in total.
The Sellers will remain shareholders of 33.0% of the share capital of Galderma. EQT’s representation on the board of directors of Galderma remains unchanged as a result of the Placement. In connection therewith, the Sellers have agreed to a 90-day lock-up period, subject to certain customary exceptions, with respect to their remaining holding in Galderma.
The Placement is expected to be settled on July 31, 2025. BNP PARIBAS, Citigroup, Goldman Sachs International, Jefferies GmbH, Morgan Stanley & Co. International plc and UBS are acting as Joint Global Coordinators and Joint Bookrunners in the Placement.
Homburger acted as transaction counsel to EQT.
The Homburger team was led by Frank Gerhard and Margrit Marti (Corporate / M&A, Capital Markets) and included Estelle Piccard, Héloïse de Jamblinne and Lucas Forrer (all Corporate / M&A, Capital Markets), Micha Fankhauser (Financial Market Regulation) as well as Stefan Oesterhelt (Tax).
Contact
Wanda Schweda / Marketing / [email protected]